US2020345650A1PendingUtilityA1

Edds chelated nanoceria with catalase-like activity

Assignee: CERION LLCPriority: Jan 20, 2015Filed: May 28, 2020Published: Nov 5, 2020
Est. expiryJan 20, 2035(~8.5 yrs left)· nominal 20-yr term from priority
Inventors:Eric L. Bell
A61K 33/244A61K 33/24A61K 33/243A61P 25/14F41C 33/0245A61K 9/10A61P 1/04A61P 17/02A61P 25/00F41C 33/008A61K 9/14A61P 25/06A61P 37/06A61P 21/00A61P 19/02A61P 25/16A61P 25/22A61K 31/197A61K 9/1688A61P 29/00A61P 3/10A61K 47/183A61P 21/02A61P 27/02A61P 25/28A61P 37/08F41C 33/048A61P 17/06A61K 9/5123A61K 47/12A61P 43/00A61K 9/0019A61P 37/02A61P 3/00F41C 33/041A61P 27/12A61P 17/16A61P 13/12A61P 35/00A61P 17/00A61P 9/00A61P 9/12A61P 11/00A61K 9/5192A61P 11/16A61P 39/06A61K 33/00A61P 9/10A61P 11/06
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A process for making nanoparticles of biocompatible materials, wherein an aqueous reaction mixture comprising cerous ion, ethylenediaminedisuccinic acid, an oxidant, water, and optionally citric acid, is provided along with temperature conditions to directly form within the reaction mixture, a stable dispersion of cerium oxide nanoparticles. Also, biocompatibe nanoparticles comprised of cerium oxide, ethyenediaminedisuccinic acid, and optionally citric acid. An increase in catalase-like enzyme activity is demonstrated by cerium oxide nanoparticles prepared with citric acid and ethylenediaminedisuccinic acid.

Claims

exact text as granted — not AI-modified
1 . A pharmaceutical composition comprising cerium oxide nanoparticies and ethylenediaminedisuccinic acid. 
     
     
         2 . A method of prophylactically treating a patient to prevent an oxidative stress related disease or an oxidative stress related event, comprising: administering a pharmaceutical composition comprising an effective amount of cerium oxide nanoparticles and ethylenediaminedisuccinic acid. 
     
     
         3 . A method of treating a symptom of an oxidative stress related disease or an oxidative stress related event in a patient, comprising: administering a pharmaceutical composition comprising an effective amount of cerium oxide nanoparticles and ethylenediaminedisuccinic acid.

Join the waitlist — get patent alerts

Track US2020345650A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.